336 related articles for article (PubMed ID: 27296670)
1. CD155 on HIV-Infected Cells Is Not Modulated by HIV-1 Vpu and Nef but Synergizes with NKG2D Ligands to Trigger NK Cell Lysis of Autologous Primary HIV-Infected Cells.
Davis ZB; Sowrirajan B; Cogswell A; Ward JP; Planelles V; Barker E
AIDS Res Hum Retroviruses; 2017 Feb; 33(2):93-100. PubMed ID: 27296670
[TBL] [Abstract][Full Text] [Related]
2. The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR.
Matusali G; Potestà M; Santoni A; Cerboni C; Doria M
J Virol; 2012 Apr; 86(8):4496-504. PubMed ID: 22301152
[TBL] [Abstract][Full Text] [Related]
3. Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu.
Shah AH; Sowrirajan B; Davis ZB; Ward JP; Campbell EM; Planelles V; Barker E
Cell Host Microbe; 2010 Nov; 8(5):397-409. PubMed ID: 21075351
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Vpu mediated downregulation of CD155 requires alanine residues 10, 14 and 18 of the transmembrane domain.
Bolduan S; Reif T; Schindler M; Schubert U
Virology; 2014 Sep; 464-465():375-384. PubMed ID: 25113908
[TBL] [Abstract][Full Text] [Related]
5. Impaired Downregulation of NKG2D Ligands by Nef Proteins from Elite Controllers Sensitizes HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.
Alsahafi N; Richard J; Prévost J; Coutu M; Brassard N; Parsons MS; Kaufmann DE; Brockman M; Finzi A
J Virol; 2017 Aug; 91(16):. PubMed ID: 28615199
[TBL] [Abstract][Full Text] [Related]
6. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD
Front Immunol; 2020; 11():40. PubMed ID: 32082316
[TBL] [Abstract][Full Text] [Related]
7. Lysis of HIV-1-infected autologous CD4+ primary T cells by interferon-alpha-activated NK cells requires NKp46 and NKG2D.
Tomescu C; Mavilio D; Montaner LJ
AIDS; 2015 Sep; 29(14):1767-73. PubMed ID: 26372382
[TBL] [Abstract][Full Text] [Related]
8. Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4⁺ T Cells.
Tremblay-McLean A; Bruneau J; Lebouché B; Lisovsky I; Song R; Bernard NF
Viruses; 2017 Oct; 9(10):. PubMed ID: 29023371
[TBL] [Abstract][Full Text] [Related]
9. Cell Surface Downregulation of NK Cell Ligands by Patient-Derived HIV-1 Vpu and Nef Alleles.
Galaski J; Ahmad F; Tibroni N; Pujol FM; Müller B; Schmidt RE; Fackler OT
J Acquir Immune Defic Syndr; 2016 May; 72(1):1-10. PubMed ID: 26656785
[TBL] [Abstract][Full Text] [Related]
10. Detection of the HIV-1 Accessory Proteins Nef and Vpu by Flow Cytometry Represents a New Tool to Study Their Functional Interplay within a Single Infected CD4
Prévost J; Richard J; Gasser R; Medjahed H; Kirchhoff F; Hahn BH; Kappes JC; Ochsenbauer C; Duerr R; Finzi A
J Virol; 2022 Mar; 96(6):e0192921. PubMed ID: 35080425
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes.
Vassena L; Giuliani E; Koppensteiner H; Bolduan S; Schindler M; Doria M
J Virol; 2015 May; 89(10):5687-700. PubMed ID: 25822027
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Nef-mediated downregulation of CD155 results in viral restriction by KIR2DL5+ NK cells.
Fittje P; Hœlzemer A; Garcia-Beltran WF; Vollmers S; Niehrs A; Hagemann K; Martrus G; Körner C; Kirchhoff F; Sauter D; Altfeld M
PLoS Pathog; 2022 Jun; 18(6):e1010572. PubMed ID: 35749424
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity.
Cerboni C; Neri F; Casartelli N; Zingoni A; Cosman D; Rossi P; Santoni A; Doria M
J Gen Virol; 2007 Jan; 88(Pt 1):242-250. PubMed ID: 17170457
[TBL] [Abstract][Full Text] [Related]
14. Identification and functional analysis of ligands for natural killer cell activating receptors in colon carcinoma.
Zhang Z; Su T; He L; Wang H; Ji G; Liu X; Zhang Y; Dong G
Tohoku J Exp Med; 2012 Jan; 226(1):59-68. PubMed ID: 22189020
[TBL] [Abstract][Full Text] [Related]
15. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
Banerjee P; Feuer G; Barker E
J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Vpu Downmodulates ICAM-1 Expression, Resulting in Decreased Killing of Infected CD4
Sugden SM; Pham TNQ; Cohen ÉA
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148794
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response.
Ward J; Davis Z; DeHart J; Zimmerman E; Bosque A; Brunetta E; Mavilio D; Planelles V; Barker E
PLoS Pathog; 2009 Oct; 5(10):e1000613. PubMed ID: 19798433
[TBL] [Abstract][Full Text] [Related]
18. HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.
Ende Z; Deymier MJ; Claiborne DT; Prince JL; Mónaco DC; Kilembe W; Allen SA; Hunter E
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321314
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses.
Prévost J; Pickering S; Mumby MJ; Medjahed H; Gendron-Lepage G; Delgado GG; Dirk BS; Dikeakos JD; Stürzel CM; Sauter D; Kirchhoff F; Bibollet-Ruche F; Hahn BH; Dubé M; Kaufmann DE; Neil SJD; Finzi A; Richard J
mBio; 2019 Jun; 10(3):. PubMed ID: 31213558
[TBL] [Abstract][Full Text] [Related]
20. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells.
Fausther-Bovendo H; Sol-Foulon N; Candotti D; Agut H; Schwartz O; Debré P; Vieillard V
AIDS; 2009 Jun; 23(9):1077-87. PubMed ID: 19424050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
